New studies point to importance of individual patient factors.
Moonshot project explores the microbiome for pathways from pre-polyp to malignancy.
With Vanderbilt’s Josh Denny selected as new CEO, NIH’s groundbreaking initiative speeds into year two.
Research adds “time factor” to machine learning to track disease evolution.
Standard indomethacin regimen may fail in infants with CYP2C9*2 variant.
Evaluating the potential to impact diagnosis and treatment.